195 related articles for article (PubMed ID: 31807070)
1. Prognostic Significance Of The Inflammatory Index-Based Scoring System In Patients Preliminarily Diagnosed With Multiple Myeloma In The Bortezomib-Based Chemotherapy Era.
Liu S; Shi J; Guo H; Xu F; Wei M; Sun K; Chen Y
Cancer Manag Res; 2019; 11():9409-9420. PubMed ID: 31807070
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell distribution width and platelet counts are independent prognostic factors and improve the predictive ability of IPI score in diffuse large B-cell lymphoma patients.
Li M; Xia H; Zheng H; Li Y; Liu J; Hu L; Li J; Ding Y; Pu L; Gui Q; Zheng Y; Zhai Z; Xiong S
BMC Cancer; 2019 Nov; 19(1):1084. PubMed ID: 31711453
[TBL] [Abstract][Full Text] [Related]
3. Association of preoperative levels of selected blood inflammatory markers with prognosis in gliomas.
Auezova R; Ryskeldiev N; Doskaliyev A; Kuanyshev Y; Zhetpisbaev B; Aldiyarova N; Ivanova N; Akshulakov S; Auezova L
Onco Targets Ther; 2016; 9():6111-6117. PubMed ID: 27785058
[TBL] [Abstract][Full Text] [Related]
4. Combination of preoperative red cell distribution width and neutrophil to lymphocyte ratio as a prognostic marker for gastric cancer patients.
Fu L; Li Q; Fan Q
J Gastrointest Oncol; 2021 Jun; 12(3):1049-1057. PubMed ID: 34295556
[TBL] [Abstract][Full Text] [Related]
5. Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma.
Kim DS; Yu ES; Kang KW; Lee SR; Park Y; Sung HJ; Choi CW; Kim BS
Korean J Intern Med; 2017 Jul; 32(4):711-721. PubMed ID: 27809455
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents.
Romano A; Parrinello NL; Consoli ML; Marchionni L; Forte S; Conticello C; Pompa A; Corso A; Milone G; Di Raimondo F; Borrello I
Ann Hematol; 2015 Nov; 94(11):1875-83. PubMed ID: 26223359
[TBL] [Abstract][Full Text] [Related]
7. Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib.
Hidalgo-Ríos S; Carrillo-García J; Moura DS; Stacchiotti S; López-Pousa A; Redondo A; Italiano A; Gutiérrez A; Grignani G; Hindi N; López-Guerrero JA; Muro XGD; Trufero JM; Palmerini E; García AS; Bernabeu D; Le Cesne A; Casali PG; Blay JY; Cruz Jurado J; Martin-Broto J
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077723
[TBL] [Abstract][Full Text] [Related]
8. Peripheral Absolute Lymphocyte Count: An Economical and Clinical Available Immune-Related Prognostic Marker for Newly Diagnosed Multiple Myeloma.
Yang Y; Liu Z; Wang H
Med Sci Monit; 2020 Jul; 26():e923716. PubMed ID: 32732863
[TBL] [Abstract][Full Text] [Related]
9. Is RDW a clinically relevant prognostic factor for newly diagnosed multiple myeloma? A systematic review and meta-analysis.
Chen X; Liu J; Duan J; Xiong H; Liu Y; Zhang X; Huang C
BMC Cancer; 2022 Jul; 22(1):796. PubMed ID: 35854269
[TBL] [Abstract][Full Text] [Related]
10. Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery.
Yu J; Ding Z; Yang Y; Liu S
Medicine (Baltimore); 2018 Jun; 97(25):e11002. PubMed ID: 29923983
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and survival values of neutrophil-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) in esophageal cancer.
Han F; Liu Y; Cheng S; Sun Z; Sheng C; Sun X; Shang X; Tian W; Wang X; Li J; Liu D; Wang Y; Zhang B; Ju Y
Clin Chim Acta; 2019 Jan; 488():150-158. PubMed ID: 30389457
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Combination of Pretreatment Red Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio in Patients with Gastric Cancer.
Zhou D; Wu Y; Lin Z; Shi L; Zhao L; Liu T; Yu D; Zhang T
Gastroenterol Res Pract; 2018; 2018():8042838. PubMed ID: 29643918
[TBL] [Abstract][Full Text] [Related]
13. [Value of Neutrophil/Lymphocyte Ratio and Monocyte/Lymphocyte Ratio in the Prognosis of Patients with Multiple Myeloma].
Yang WH; Sun YQ; Zhang QK; Wei XF; Li G
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):122-130. PubMed ID: 33554808
[TBL] [Abstract][Full Text] [Related]
14. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients.
Zhang F; Chen Z; Wang P; Hu X; Gao Y; He J
Tumour Biol; 2016 Jul; 37(7):9323-31. PubMed ID: 26779631
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of pretreatment inflammatory biomarkers as independent prognostic indicators in prostate cancer.
Sun Z; Ju Y; Han F; Sun X; Wang F
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28605139
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving borte- zomib-based therapy for multiple myeloma.
Zhou X; Wang J; Xia J; Cheng F; Mao J; Zhu J; Guo H
Cancer Biomark; 2018; 22(1):43-48. PubMed ID: 29562497
[TBL] [Abstract][Full Text] [Related]
17. [Significance of Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients with Multiple Myeloma].
Sun JY; Mu N; Mu J; Zhang CG; Wang DM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1185-1189. PubMed ID: 31418377
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment neutrophil/lymphocyte ratio but not platelet/lymphocyte ratio has a prognostic impact in multiple myeloma.
Li Y; Li H; Li W; Wang L; Yan Z; Yao Y; Yao R; Xu K; Li Z
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27925303
[TBL] [Abstract][Full Text] [Related]
19. Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project.
D'Agostino M; Cairns DA; Lahuerta JJ; Wester R; Bertsch U; Waage A; Zamagni E; Mateos MV; Dall'Olio D; van de Donk NWCJ; Jackson G; Rocchi S; Salwender H; Bladé Creixenti J; van der Holt B; Castellani G; Bonello F; Capra A; Mai EK; Dürig J; Gay F; Zweegman S; Cavo M; Kaiser MF; Goldschmidt H; Hernández Rivas JM; Larocca A; Cook G; San-Miguel JF; Boccadoro M; Sonneveld P
J Clin Oncol; 2022 Oct; 40(29):3406-3418. PubMed ID: 35605179
[TBL] [Abstract][Full Text] [Related]
20. [Clinical Application of R-ISS Staging System in 412 Newly Diagnosed Patients with Multiple Myeloma].
Chen HM; Wei W; Peng R; Shi HT; Chen XL; Wu LX; Zhou N; Zhou F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):110-114. PubMed ID: 30738456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
